WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)
South Korea · Delayed Price · Currency is KRW 6,600.00
+300.00 (4.76%)
At close: Jul 10, 2026
KOSDAQ:330350 Market Cap
KOSDAQ:330350 has a market cap or net worth of 87.12 billion as of July 10, 2026. Its market cap has decreased by -17.10% in one year.
Market Cap
87.12B
Enterprise Value
86.96B
Revenue
108.89B
Ranking
n/a
PE Ratio
11.95
Stock Price
6,600.00
Market Cap Chart
Since July 3, 2020, KOSDAQ:330350's market cap has decreased from 302.46B to 87.12B, a decrease of -71.20%. That is a compound annual growth rate of -18.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 87.12B | -23.45% |
| Dec 30, 2025 | 113.80B | 22.44% |
| Dec 30, 2024 | 92.94B | -27.60% |
| Dec 28, 2023 | 128.37B | 3.84% |
| Dec 29, 2022 | 123.62B | -10.73% |
| Dec 30, 2021 | 138.48B | -26.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HYUNDAI BIOLAND | 106.80B |
| OPTUS Pharmaceutical | 105.53B |
| BL Pharmtech | 101.73B |
| DongKoo Bio & Pharma | 101.54B |
| H.PIO | 90.60B |
| KOREA PHARMA | 86.82B |
| Daehan Nupharm | 80.42B |
| Sam-A Pharm. | 78.24B |